Lobbying client

ALORA PHARMACEUTICALS, LLC

Drug manufacturer.

Filings
13
Filed by
1
Reported in-house
—
Reported by firms
$870,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2023 to 2026

Filings

13 filings, newest first.
Filing Filed by Amount
3rd Quarter - Termination
3rd Quarter 2023
THORN RUN PARTNERS $50,000 reported
3rd Quarter - Reportreplaced
3rd Quarter 2023
THORN RUN PARTNERS $50,000 reported
Registration
3rd Quarter 2023
THORN RUN PARTNERS — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
THORN RUN PARTNERS 10 $870,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 12

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 2707 118th 2

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.